{"DataElement":{"publicId":"6770418","version":"1","preferredName":"Specimen Tumor Grading System Histologic Grade","preferredDefinition":"Grades to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","longName":"6770643v1.0:6770408v1.0","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"6770643","version":"1","preferredName":"Specimen Tumor Grading System","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome.  It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation.  Malignant tumors usually are graded I-III.","longName":"2241613v1.0:2431229v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431229","version":"1","preferredName":"Grading System","preferredDefinition":"definition pending","longName":"C48224","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Grading System","conceptCode":"C48224","definition":"A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome.  It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation.  Malignant tumors usually are graded I-III.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE451-6154-3394-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F64003-E441-124E-E053-F662850A14C2","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-28","modifiedBy":"ZHANGWE","dateModified":"2019-12-31","changeDescription":"5/28/19 jk created for UWI2016-07-01, Path Characteristics tab.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6770408","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A position on a scale of intensity or amount or quality.","longName":"6770408v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"In situ","valueDescription":"In Situ","ValueMeaning":{"publicId":"4579513","version":"1","preferredName":"In Situ","longName":"4579513v1.00","preferredDefinition":"In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ","conceptCode":"C14160","definition":"In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"079769AF-53B7-1361-E050-BB89AD435164","latestVersionIndicator":"Yes","beginDate":"2014-11-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2014-11-11","modifiedBy":"GDEEN","dateModified":"2023-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-31B7-641F-E053-F662850A1ABA","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Unknown/Not specified","valueDescription":"Unspecified Unknown","ValueMeaning":{"publicId":"2784498","version":"1","preferredName":"Unspecified Unknown","longName":"2784498v1.00","preferredDefinition":"Not stated explicitly or in detail._Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56BA1404-2475-1596-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-09-12","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-31CC-641F-E053-F662850A1ABA","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Grade I","valueDescription":"Well Differentiated","ValueMeaning":{"publicId":"3685458","version":"1","preferredName":"Well Differentiated","longName":"3685458v1.00","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A18-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-31E1-641F-E053-F662850A1ABA","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Grade II","valueDescription":"Moderately Differentiated","ValueMeaning":{"publicId":"2559269","version":"1","preferredName":"Moderately Differentiated","longName":"2559269v1.00","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B492-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-31EB-641F-E053-F662850A1ABA","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Grade III","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"3685459","version":"1","preferredName":"Poorly Differentiated","longName":"3685459","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A3B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-31FF-641F-E053-F662850A1ABA","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Grade IV","valueDescription":"Undifferentiated Histology","ValueMeaning":{"publicId":"2560389","version":"1","preferredName":"Undifferentiated Histology","longName":"2560389v1.00","preferredDefinition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B8F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3F31E-3209-641F-E053-F662850A1ABA","beginDate":"2008-09-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":null,"ValueMeaning":{"publicId":"7590024","version":"1","preferredName":"Not Applicable","longName":"7590024","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCB96B6E-DDC3-6924-E053-4EBD850AEF18","latestVersionIndicator":"Yes","beginDate":"2021-03-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2021-03-04","modifiedBy":"KUMMEROA","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":"7/8/22 added alt name of NA for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01660680-2A71-4D2F-E063-731AD00A4A8D","beginDate":"2023-07-26","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-07-26","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2786701","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Of or relating to histology.:A position on a scale of intensity or amount or quality.","longName":"C25526:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57451CD6-05F6-28B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-19","modifiedBy":"ONEDATA","dateModified":"2008-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3F31E-3195-641F-E053-F662850A1ABA","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":"05/28/2019 created for DCP SVAR UWI2016-07-01#SVARProtocol04302019, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Differentiation","type":"Preferred Question Text","description":"Differentiation","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3F31E-323A-641F-E053-F662850A1ABA","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"LISU","dateModified":"2020-05-05","changeDescription":"5/28/2019 created for DCP SVAR UWI2016-07-01#SVARProtocol04302019, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}